Purchase Order N0016724P0229

Award Date 8/28/24
Potential Completion Date 9/11/24
Potential Value $23K
Ultimate Awardee
Not listed
PSC Category
8040 - Adhesives
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $100,600.00 firm fixed price purchase order awarded by the Naval Air Warfare Center (NAVAIR) to Ecosil Technologies, LLC, a for-profit limited liability company, for a VALIDATION/DEMONSTRATION project. The contract has an ultimate completion date of August 1, 2017 and was awarded on August 2, 2016. This award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,719.10, is for the provision of PADCEV 30 MG VIALS, a medical product. The contract has a period of performance that ends on February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,754.64 firm fixed-price delivery order contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,499.51, is for the supply of PADCEV 30 MG VIALS medical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen is the prime contractor, and the contract was not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.20 firm fixed price delivery order is for the supply of VEKLURY 100 MG VIALS, which are likely antiviral medications. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,808.94, is for the provision of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $21,904.47 with a Firm Fixed Price pricing type. The contract was awarded on October 26, 2023 with an ultimate completion date of November 17, 2023. The contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. This award is not designated as a set-aside contract....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm-fixed-price contract is for the delivery of VEKLURY 100 MG vials and has a completion date of February 29, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,886.60 Firm Fixed Price delivery order is for the procurement of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...

This is a $23,293.60 firm-fixed-price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA) to Evonik Corporation, a leading specialty chemicals manufacturer, for the supply of VERSALINK P1000 products. The contract has an ultimate completion date of September 11, 2024 and was awarded on August 28, 2024 with no set-aside designation. Evonik has a history of providing materials such as adhesives, resins, foams, and isocyanates to support various defense projects as both a prime contractor and subcontractor. This award is part of Evonik's broader work with the U.S. government, including over $880 million in federal grants from the Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to support COVID-19 vaccine manufacturing and medical countermeasure development.

Generated 3/21/25, 9:51 AM